The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
14 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $16,787,339 in first-year total cost, median $657,825.
Most frequent study sections
- Emerging Imaging Technologies in Neuroscience Study Section[EITN]3
- Special Emphasis Panel[ZRG1 MDCN-E (56)]2
- Special Emphasis Panel[ZRG1 MDCN-P (56)]2
- Special Emphasis Panel[ZRG1-MDCN-P(56)R]2
- Cellular and Molecular Biology of Neurodegeneration Study Section[CMND]1
Most frequent institutions
- J. DAVID GLADSTONE INSTITUTES2
- UNIV OF NORTH CAROLINA CHAPEL HILL2
- EMORY UNIVERSITY1
- MASSACHUSETTS GENERAL HOSPITAL1
- NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Understanding Selectivity Mechanisms of Network Vulnerability and Resilience in Alzheimer's Disease by Establishing a Neurobiological Basis through Network Neuroscience1RF1AG068399-01 | WU, GUORONG | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $1,939,894 | EITN |
| 2020 | Cell type influence on exosome signaling and early pathologic signatures in Alzheimers disease1R56AG062618-01A1 | BALDWIN, KRISTIN KAYCLINE, HOLLIS T. | SCRIPPS RESEARCH INSTITUTE, THE, CA | $887,070 | ZRG1 |
| 2020 | 3D Reconstruction and Analysis of Alzheimer's Patient Biopsy Samples to Map and Quantify Hallmarks of Pathogenesis and Vulnerability1R01AG065549-01 | ELLISMAN, MARK H | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $746,606 | EITN |
| 2020 | Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome1R01AG064579-01A1 | FINKBEINER, STEVEN M | J. DAVID GLADSTONE INSTITUTES, CA | $663,249 | CMND |
| 2020 | Connectomic Biomarkers of Preclinical Alzheimer's Disease within Multi-Synaptic Pathways1R56AG068261-01 | AGANJ, IMAN | MASSACHUSETTS GENERAL HOSPITAL, MA | $562,673 | EITN |
| 2020 | The role of ectodermal-neural cortex 1 in selective neuronal vulnerability in aging and Alzheimer's disease1R56AG066782-01 | FU, HONGJUN | OHIO STATE UNIVERSITY, OH | $498,043 | ZRG1 |
| 2020 | Impact of locus coeruleus-derived tau pathology in a rodent model of early Alzheimer's disease1R01AG062581-01A1 | KEILHOLZ, SHELLA DWEINSHENKER, DAVIDWEISS, JAY MICHAEL | EMORY UNIVERSITY, GA | $434,665 | ZRG1 |
| 2020 | Cell-type-specific vulnerability of the entorhinal cortex in Alzheimer's disease1R01AG066806-01 | IGARASHI, KEI M | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $392,084 | ZRG1 |
| 2019 | High-throughput mapping of selectively vulnerable cell types and projections in aging and Alzheimer's Disease1RF1AG064049-01 | LEE, KUO-FENZADOR, ANTHONY M | SALK INSTITUTE FOR BIOLOGICAL STUDIES, CA | $4,710,797 | MNG |
| 2019 | A Nonhuman Primate Model of Early Alzheimer's Disease Pathogenesis1RF1AG063837-01 | BAXTER, MARK GBLISS-MOREAU, ELIZAMORRISON, JOHN H | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $3,790,223 | LAM |
| 2019 | Deciphering molecular pathways of inhibitory interneuron dysfunction in Alzheimer's disease1R01AG062629-01 | PALOP, JORGE J | J. DAVID GLADSTONE INSTITUTES, CA | $712,548 | ZRG1 |
| 2019 | Socioeconomic Mediators of Adult Brain Network Resilience and Vulnerability to Cognitive Decline1R01AG063930-01 | WIG, GAGAN S | UNIVERSITY OF TEXAS DALLAS, TX | $652,400 | CP |
| 2019 | Identification and manipulation of whole-brain memory traces following age-related cognitive decline or Alzheimer's disease1R56AG058661-01A1 | DENNY, CHRISTINE ANN | NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC, NY | $405,000 | ZRG1 |
| 2019 | Redundancy as a neuroprotective mechanism against aging-related cognitive decline1R01AG062590-01 | DAYAN, ERAN | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $392,087 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.